Lei Jianping on January 9
iFLYTEK (stock code: 002230) announced today that the company intends to spin off its holding subsidiary, iFLYTEK Medical, to be listed on the main board of the Hong Kong Stock Exchange.
The issuance size of iFLYTEK Medical does not exceed 15% of the total share capital after the issuance, and the issuance method is a Hong Kong public offering and an international placement of new shares.
iFLYTEK is a comprehensive artificial intelligence company, whose main business includes core AI application scenarios and industrial chain links such as smart education, open platform and consumer business, smart city, operator, smart car, smart finance, and smart healthcare.
iFLYTEK said that the proposed spin-off assets iFLYTEK Medical will carry out R&D and services in the medical field, and rely on its own artificial intelligence technology related to the medical industry to carry out project development, system operation and maintenance, product sales and other main business activities in the fields of auxiliary diagnosis and treatment, medical insurance management, and intelligent hardware.
After the completion of this spin-off, iFLYTEK Medical will deeply cultivate the medical industry market, and iFLYTEK will focus on improving the performance level of the product layout of artificial intelligence core technologies and general large models and other major application scenarios.
The annual revenue was 494 million and the net loss was 260 million
According to reports, iFLYTEK Medical is an enterprise that uses AI to empower China's medical industry, with the mission of creating "AI diagnosis and treatment assistant for every doctor and AI health assistant for everyone".
Through leading core technologies such as speech recognition, image recognition, and natural language understanding, iFLYTEK is committed to deeply integrating artificial intelligence technology with the medical industry, promoting the development of the health care industry, and helping the implementation of national medical reform policies.
iFLYTEK has achieved good results in improving the informatization and intelligence level of hospitals, improving the diagnosis and treatment capabilities of grassroots doctors, and empowering medical institutions at all levels, regional management platforms, residents and patients.
According to the announcement, iFLYTEK Medical's revenue in 2020, 2021, and 2022 will be 320 million yuan, 356 million yuan, and 494 million yuan respectively, and the net loss will be 19.23 million yuan, 103 million yuan, and 260 million yuan respectively, and the net profit after deducting non-profits will be 14.28 million yuan, -83.56 million yuan, and -216 million yuan respectively.
iFLYTEK directly holds 52.47% of the shares
iFLYTEK Medical's equity was also subsequently exposed. According to the announcement, iFLYTEK Co., Ltd. holds 52.47% of the shares of iFLYTEK Medical, Hefei Zhengsheng Information Technology Partnership (Limited Partnership) holds 17.11% of the shares, Anhui Kexun Venture Capital Fund Partnership (Limited Partnership) holds 15.03% of the shares, Hu Guoping holds 3.94% of the shares, Shenzhen Tianzheng Investment Co., Ltd. holds 3.43% of the shares, and Zibo Jizhi Equity Investment Fund Partnership (Limited Partnership) holds 1.53% of the shares;
Shanghai Shuiyao Enterprise Management Consulting Services Co., Ltd. holds 1.32% of the shares, Anhui Yanzhi Technology Co., Ltd. holds 1.19% of the shares, and iFLYTEK Haihe (Tianjin) Artificial Intelligence Venture Capital Fund Partnership (Limited Partnership) holds 1.13% of the shares;
Hainan Yuntong Equity Investment Partnership (Limited Partnership) holds 0.92% of the shares, and Hefei Tongchuang SME Development Fund Partnership (Limited Partnership) holds 0.66%;
Shenzhen Guoke Ruihua Phase III Equity Investment Fund Partnership holds 0.66% of the shares, Shanghai Guyu Nange Science and Technology Development Center Limited Partnership holds 0.36% of the shares, and Hefei Kexun Lianshan Innovation Industry Investment Fund Partnership (Limited Partnership) holds 0.26% of the shares.
iFLYTEK is the controlling shareholder of iFLYTEK Medical, and Liu Qingfeng and HKUST Holdings are the actual controllers of iFLYTEK Medical.
———————————————
Lei Di was founded by Lei Jianping, a media person, if it is reprinted, please indicate the source.